KS-619-1, a new inhibitor of Ca2+ and calmodulin-dependent cyclic nucleotide phosphodiesterase, was isolated from the cultured broth of Streptomyces californicus. KS-619-1 has an anthraquinone moiety. IC50 values for the effect of KS-619-1 on Ca2+ and calmodulinstimulated activity of bovine brain and heart enzymes were 2.0 and 1.5 [jm, respectively. On the other hand, basal activity (the activity in the presence of ethylene bis(oxyethylenenitrilo)-tetraacetic acid (EGTA) instead of Ca2+/calmodulin) of the bovine brain enzyme, calmodulinindependent cyclic nucleotide phosphodiesterase from bovine heart, and protein kinase C from rat brain were inhibited by KS-619-1 to a lesser extent with IC50 values; 12.3, 25.9 and 151 wm, respectively.
In a previous paper6), we showed that K-259-2 was isolated from the cultured broth of Micromonosporaolivasterospora as a novel inhibitor of Ca2 + and calmodulin-dependent cyclic nucleotide phosphodiesterase (CaM-PDE) . In this article, we describe the fermentation, isolation, physico-chemical properties and biochemical properties of another new potent CaM-PDE inhibitor from Streptomyces californicus. The compound, named KS-61 9-1 , was active in the micromolarf range, and its structure was determined to be 1 ( Fig. 1) , which also contained the anthraquinone moiety like K-259-2. Subsequent paper70 will elucidate studies on the structural determination.
Materials and Methods Fermentation
To a 50-ml test tube was added 15 ml of a seed mediumcomposed of glucose 1.0%, soluble starch 1.0%, beef extract 0.3%, yeast extract 0.5%, Bacto-tryptone 0.5% and CaCO3 0.2% (pH 7.2 before sterilization) and inoculated with a loopful of spores of the microorganism, Streptomyces californicus KY619 (ATCC3312), grown on a surface of an agar slant. The composition of the agar slant medium (Hickey-Tresner) consisted of soluble starch 1.0%, N-Z amine type A 0.2%, beef extract 0.1 %, yeast extract 0.1 % and agar 2.0% (pH 7.2 before sterilization). The inoculated tube was incubated for 24 hours on a reciprocating shaker (300 rpm) at 28°C. An 10%-inoculum was made from the above vegetative medium to 300-ml Erlenmeyer flasks containing 40 ml of the same medium. This second stage vegetative mediumwas incubated for 24 hours on a rotary shaker (200 rpm) at 28°C. Four ml of this seed culture was transferred into a 300-ml flask containing 40 ml of production medium composed of glycerol 3.0%, beef extract 3.0%, K2HPO4 0.05%, MgSO4-7H2O 0.05%, KC1 0.03% and CaCO3 0.3% (pH 6.5 after sterilization).
This production medium was incubated for 5 days on a rotary shaker (200 rpm) at 28°C. For inoculation of 18 liters of the production medium in 30-liter jar fermentors, a 30 ml-aliquot of the second stage vegetative mediumwas transferred into 2-liter Erlenmeyer flasks containing 300 ml of the same seed medium. This third stage vegetative mediumwas incubated for 24 hours on a rotary shaker (200 rpm) at 28°C; 5.0% inoculum was routinely used for inoculation of the production medium. The fermentor was operated for 4 days at 28°C with agitation at 300 rpm and aeration of 18 liters/minute.
The growth was monitored by packed cell volume (PCV). KS-619-1 was produced in broth filtrate, and its production was traced by measuring the inhibitory activity of CaM-PDE.The amount of KS-619-1 was determined spectrophotometrically using pure KS-619-1 as a standard on TLC plate (Silica gel 60, Merck, 5628) developed with BuOH-EtOH -CHC13 -NH4OH (4 : 5 : 2 : 3). The plate was scanned at the wavelength of460 nm with a Shimadzu Dual-wavelength TLC Scanner CS900.
EnzymeAssay
CaM-PDE and its basal (in the presence of ethylene bis(oxyethylenenitrilo)tetraacetic acid (EGTA) instead of Ca2+/CaM)activities, CaM-independent PDEactivity, and protein kinase C activity were measured as described previously8). Materials Bovine brain CaM-PDE and CaMwere prepared according to the method of Kakiuchi et a/.9) with some modifications^. Protein kinase C was prepared from rat brain according to the method of Kikkawa et aL10) with some modifications as described in a previous paper8). Bovine heart CaM-PDE and CaM-independent PDE, CAMP,and 5/-nucleotidase {Crotalus atrox venom) were purchased from Sigma Chemical Co. All other reagents were reagent grade and commercially available.
Results
Production of KS-619-1 by Fermentation Fig. 2 shows a time course of KS-619-1 production by the producing microorganism in 30-liter jar fermentor. The production of KS-619-1 gradually increased during growth phase and was rapidly increased on day 4 after the cell growth reached the maximum. The effect of carbon sources and natural nitrogen sources on the production of KS-619-1 were investigated (Table 1 -A and -B). The additions of glycerol as a carbon source and beef extract as a nitrogen source were the most influencial to obtain the best titers for the production of KS-619-1.
Numerousattempts to increase the biosynthesis of KS-619-1 were conducted, and the resultant defined medium and the optimum conditions for the production were described under Materials and Methods. Isolation and Purification Isolation procedure is outlined in Fig. 3 . The fermentation broth (36 liters) was centrifuged with Sharpies centrifuge. The supernatant was then applied onto a column of Diaion HP-10 (Mitsubishi Chemical Industries Ltd.). The column was washed with water and then 30% methyl alcohol successively, and adsorbed material was eluted with methyl alcohol. The eluate was concentrated in vacuo, and extracted with ethyl acetate. The ethyl acetate layer was dried over sodium sulfate and then concentrated in vacuo to yield oily brown material (2.0 g). This oily material was applied to silica gel column chromatography. Fractions containing crude KS-619-1 were pooled and concentrated downto an oil (130 mg). The residue was fractionated on second silica gel column chromatography. Fractions containing KS-619-1 was collected and concentrated in vacuo to yield oily material (71 mg). The resultant oily material was further applied to third silica gel column. The appropriate fractions were pooled and evaporated to dryness (57 mg). Final purification of the compound was achieved by Sephadex LH-20 (Pharmacia Fine Chemicals) column. Fractions containing KS-619-1 were combined and evaporated to yield a dark red powder (9.7 mg).
Physico-chemical Properties Physico-chemical properties of KS-619-1 are summarized in Table 2 . KS-619-1 was obtained as orange powder, mp 198~200°C (dec).
It is soluble in dimethyl sulfoxide and acetic acid, slightly soluble in the lower alcohols, and virtually insoluble in chloroform and water. Its absorption spectra (Fig. 4) in UVand visible regions shift with pH. The Rf values of the compound on silica gel TLCdeveloped in various solvent systems and its color reactions are also presented in Table 2 . The structure of KS-619-1 was determined to be 1 (Fig. 1) on the basis of physico-chemical analysis and various spectral data. Details of these studies will be described in a separate paper.
Biochemical Properties Fig. 5 shows the effect of various concentration of KS-619-1 on the activity of CaM-PDE from bovine brain.
KS-619-1 inhibited the stimulated activity by Ca2+/CaMin a concentration-dependent manner, whereas it showed a less degree of inhibitory effect on its basal activity (the activity in the presence of EGTAinstead of Ca2+/CaM); IC50 values (the concentration producing 50% inhibition) under present assay conditions were 2.0 and 12.3^m, respectively. Table 3 summarizes the effect of KS-619-1 on the activity of several cyclic nucleotide phosphodiesterases. KS-619-1 also inhibited CaMPDEfrom bovine heart in the same concentration range (IC50 value, 1.5 jum) as the case of the bovine brain enzyme. In addition, CaM-independent PDEfrom bovine heart was only weakly inhibited by KS-619-1; the IC50 value was 25.9 jam. The inhibitory activity of KS-619-1 for protein kinase C (IC50 value, 151^m) was much less than that for CaM-PDE. Taken together,
the results presented here demonstrate that KS-619-1 is a novel potent inhibitor of CaM-PDE. Phosphodiesterase activity was measured as described in a previous paper8) with various concentrations of KS-619-1 added as indicated. For the assay of Ca2+/CaM-stimulated activity ($), the reaction mixture contained, in a final volume of 0.5 ml, 80him imidazole-HCl buffer (pH 6.9), 3 mMMgSO4, 0.3 him dithiothreitol, 100 mMNaCl,
CaCl2, 26mu/ml bovine brain CaM-PDE, and 4u/ml CaM. The basal activity (O) was determined using a large amount of the enzyme (18.6mu/ml) to magnify PDE activity in the presence of 3 mMEGTAinstead of Ca2+/CaM. Bovine heart CaM-PDE +e 2.5 Bovine heart CaM-independent PDE -d 25.9 a The activity in the presence of 4 u/ml calmodulin, and 50 {jlm CaCl2. The enzyme concentration was 26 mu/ml. b The activity in the presence of 3 him ethylene bis(oxyethylenenitrilo)tetraacetic acid (EGTA), without CaCl2 and calmodulin. The enzyme concentration was 18.6 mu/ml. c The activity in the presence of 2.5 u/ml calmodulin, and 50 fiM CaCl2. The enzyme concentration was 40 mu/ml. d The activity in the presence of 3 him EGTA,without CaCl2 and calmodulin. The enzyme concentration was 25 mu/ml.
CaM: Calmodulin. CaM-PDE: Ca2+ and calmodulin-dependent cyclic nucleotide phosphodiesterase.
KS-619-1 at lOO^g/ml exhibited no antimicrobial activity against Candida albicans KY 5011, Enterococcus faecalis KY 4280, Pseudomonas aeruginosa KY 4276, Escherichia coli KY 4271, Bacillus subtilis KY 4773, Proteus vulgaris KY 4277, Shigella sonnei KY 4281, Salmonella typhosa KY4278 or Klebsiella pneumoniae KY 4275, but it showed only a weak antimicrobial activity at 50^g/ml against Staphylococcus aureus KY4779.
Discussion
Several CaM-dependent enzymes can be inhibited by a wide range of chemically unrelated substances in vitroll) ; these include phenothiazines12), naphthalensulfonamide compounds {e.g., W-7)13), alkaloids (e.g., vinblastine)14' 15) , local anesthetics16) , and antimycotic agents (e.g., calmidazorium)17> 18).
Because almost all CaMantagonists presently available interact with lipid10), they also inhibit protein kinase C, which is thought to regulate a variety of cellular responses20»21), in the similar concentration range22). Amongthese so-called CaMantagonists is adriamycin, an anthracycline-aminoglycoside antitumor antibiotic; it has also an anthraquinone moiety. Adriamycin inhibits weakly CaM-activated protein kinase (IC50 value, 50~85 /^m23)) or other CaM functions (30-300^m24)) by acting at a hydrophobic region of CaM,and it also antagonizes protein kinase C at the similar concentration2^. Adriamycin inhibited CaM-PDEactivity only weakly under the present assay conditions described above (IC50 value, 700^m, data not shown), whereas the novel anthraquinone metabolite, named KS-619-1, inhibited this activity intensely (IC50 value, 2.0 fiM). The ability to inhibit the CaM action of adriamycin is therefore much less than that of KS-619-1. Furthermore, it is noteworthy of comment that the IC50 value for the effect of KS-619-1 on protein kinase C was 151 tm, which is two orders of magnitude higher than that for CaM-PDE. Experiments to be described elsewhere have shown that well-known CaM antagonists, if not all, interact with amphipathic (hydrophobic plus anionic) compoundssuch as acidic phospholipids as discussed above in contrast with KS-619-1, which does not interact. To clarify whether or not the strong inhibitory activity of KS-619-1 as compared with adriamycin can be explained by this non-interacting property with amphipathic compounds, detailed mechanisms by which KS-619-1 acts are now under investigations.
In conclusion, KS-619-1 is a novel potent inhibitor of CaM-PDE and its significant feature will be helpful to unravel the physiological functions of calmodulin in Ca2 + -messenger system.
